Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Translocator protein | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 4 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 2 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 2 | 1 | 5 |
B1 bradykinin receptor | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
PAX8 | 0 | 0 | 0 | 1 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
TDP1 protein | 4 | 0 | 0 | 4 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
Smad3 | 1 | 0 | 0 | 1 |
67.9K protein | 2 | 0 | 0 | 2 |
IDH1 | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
geminin | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 3 | 2 | 5 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Histamine H4 receptor | 0 | 2 | 2 | 4 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
AR protein | 5 | 0 | 0 | 5 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Estrogen receptor | 0 | 6 | 1 | 7 |
Glucocorticoid receptor | 0 | 4 | 0 | 4 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 6 | 0 | 6 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 6 | 0 | 6 |
Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
polyprotein | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 0 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 1 | 2 | 3 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Plasminogen | 0 | 2 | 1 | 3 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |